This inventor holds 3 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Amgen Inc., Amgen Research (Munich) Gmbh. Active years: 2016-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Seattle, WA (US) (2016)
- Wellesley, MA (US) (2019 - 2022)
Company Filing History:
3 out of 2,074 
1 out of 77 
Years Active: 2016-2022
Title: Ramil F Latypov: Innovator in Pharmaceutical Compositions
Introduction
Ramil F Latypov is a notable inventor based in Wellesley, MA (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 3 patents. His work primarily focuses on innovative compositions that enhance therapeutic efficacy.
Latest Patents
Latypov's latest patents include a pharmaceutical composition comprising bispecific antibody constructs. This invention provides novel and stable pharmaceutical compositions that include bispecific single chain antibody constructs, cyclodextrins, and a buffer. Another significant patent is for lyophilized therapeutic peptibody formulations, which offers long-term stable formulations of a lyophilized therapeutic peptibody and methods for creating such compositions.
Career Highlights
Throughout his career, Ramil F Latypov has worked with prominent companies in the pharmaceutical industry, including Amgen Inc. and Amgen Research (Munich) GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas in drug formulation.
Collaborations
Latypov has collaborated with esteemed colleagues such as William Callahan and Richard L Remmele, Jr. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Ramil F Latypov stands out as a significant figure in the pharmaceutical industry, with a focus on innovative compositions that improve therapeutic outcomes. His contributions through patents and collaborations highlight his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile